Launch Insights

MDOutlook® Delivers Precision Intelligence

ASH 2021 Recap: 20-Year Analysis of the Expansion in Hematology In recognition and preparation of ASH 2021 (American Society of Hematology 2021 Meeting), the MDOutlook team analyzed more than 30 million publications for author collaborations in hematology since 2002. Over a period of 2 weeks, we produced valuable insights that
Read more
Bias is often a major concern in life sciences market research. The third party Key Opinion Leader (KOL) and clinician panels on which many market research organizations rely can be particularly susceptible; recruiting physicians using standard lists, from multi-disciplinary patient management in varied institutional settings, often doesn’t give commercial teams
Read more
I remember it like it was yesterday. I was a regional marketing manager at Pfizer in the early 2000’s, and I spent a large portion of my time and marketing budget focused on our cardiovascular (CVD) disease portfolio. Although I was largely focused on CVD at the time, the lessons
Read more
Some medical professionals can make or break a product launch. These are the ThoughtLeaders ("TLs", also known as Scientific Leaders or Key Opinion Leaders, "KOLs"): the experts who are published in medical journals, direct clinical development, sit on advisory boards, lead professional societies, chair guidelines committees, and speak at conferences
Read more
Wondering how to engage HCPs? Read this article to find learn more
Read more
In this article, MDOutlook will discuss how Key Opinion Leaders use their influence to play a instrumental role in building a brand.
Read more
In this article, MDOutlook will discuss how Key Opinion Leaders use their influence to play a instrumental role in building a brand.
Read more
Learn how medical market research is often conducted to understand and inform many different aspects of diseases, conditions and products.
Read more
When a life sciences company prepares to launch a new treatment or product, support from leading voices can be a critical component of success. These “leading voices” are called ThoughtLeaders (TLs). Thoughtleaders in healthcare are the most valuable launch catalysts to target for a treatment launch. Let’s consider why ThoughtLeader
Read more
Engaging healthcare providers (HCPs) is ever important for pharmaceutical and life sciences companies. Even though technology afforded new ways of engaging HCPs, real-world events like the COVID-19 pandemic also shape effective engagement strategies. Take a look at the importance of engaging HCPs, how COVID-19 had an impact, and tips for
Read more
The market for pharmaceuticals and life sciences treatments has become increasingly complex, and the global pandemic has only added to the challenges of reaching ThoughtLeaders (TLs also known as Key Opinion Leaders – KOLs) and clinicians. This trend is largely driven by the high volume of existing options available for
Read more
At the onset of a new life sciences treatment, advocacy from the right clinicians is critical for success. However, clinicians are not easily accessible. These professionals carry a lot of responsibilities, are pressed for time, and new treatments may struggle to garnertheir attention. Building an effective clinician engagement strategy is
Read more
For a pharmaceutical brand to have an effective voice in today’s saturated market, it needs access to the right pharmaceutical ThoughtLeaders and clinicians. As you are aware, ThoughtLeaders (TLs) at all levels (global, national, regional, local) play a vital role in treatment adoption, formulary access and helping define beliefs about
Read more
Challenges continue to mount for pharmaceutical market researchers in a healthcare market where it is increasingly difficult to reach properly qualified healthcare providers and patients. Lack of appropriate market research respondents makes it difficult to piece together the "big picture" of how a treatments are perceived and utilized by payers,
Read more
ASH 2021 Recap: 20-Year Analysis of the Expansion in Hematology In recognition and preparation of ASH 2021 (American Society of Hematology 2021 Meeting), the MDOutlook team analyzed more than 30 million publications for author collaborations in hematology since 2002. Over a period of 2 weeks, we produced valuable insights that
Read more
Bias is often a major concern in life sciences market research. The third party Key Opinion Leader (KOL) and clinician panels on which many market research organizations rely can be particularly susceptible; recruiting physicians using standard lists, from multi-disciplinary patient management in varied institutional settings, often doesn’t give commercial teams
Read more
I remember it like it was yesterday. I was a regional marketing manager at Pfizer in the early 2000’s, and I spent a large portion of my time and marketing budget focused on our cardiovascular (CVD) disease portfolio. Although I was largely focused on CVD at the time, the lessons
Read more
Some medical professionals can make or break a product launch. These are the ThoughtLeaders ("TLs", also known as Scientific Leaders or Key Opinion Leaders, "KOLs"): the experts who are published in medical journals, direct clinical development, sit on advisory boards, lead professional societies, chair guidelines committees, and speak at conferences
Read more
Three Ways to Identify and Activate ThoughtLeaders

3 Ways To Identify And Activate ThoughtLeaders Webinar

In this webinar, we will help you (1) go deeper in identifying your ThoughtLeaders in a specific disease area, (2) to target your ThoughtLeaders for the right type of activity and (3) provide you the foundation for building stronger relationships with specific ThoughtLeaders and their influence networks.

Read More »
Webinar Cover

Performance Tracking To Stay Ahead Of The Curve On-Demand Webinar

You need brand and market insights yesterday! You are not satisfied with the insights provided because each time you receive them, they are out of date. You want to stay one step ahead. In this webinar, we share ways that you can stay ahead by reacting in time through informed confident business decisions.

Read More »